Amundi Asset Management US’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
$148M Sell
529,457
-8,895
-2% -$2.49M 0.11% 197
2020
Q4
$132M Buy
538,352
+34,888
+7% +$8.54M 0.11% 200
2020
Q3
$143M Sell
503,464
-416,527
-45% -$118M 0.15% 143
2020
Q2
$246M Sell
919,991
-248,921
-21% -$66.6M 0.29% 73
2020
Q1
$370M Buy
1,168,912
+308,789
+36% +$97.7M 0.64% 29
2019
Q4
$255M Buy
860,123
+633,249
+279% +$188M 0.3% 83
2019
Q3
$52.8M Sell
226,874
-2,594
-1% -$604K 0.08% 265
2019
Q2
$53.7M Sell
229,468
-54,415
-19% -$12.7M 0.04% 303
2019
Q1
$67.1M Sell
283,883
-208,729
-42% -$49.3M 0.09% 220
2018
Q4
$148K Buy
492,612
+232,725
+90% +$70K 0.14% 119
2018
Q3
$91.8M Buy
259,887
+58,368
+29% +$20.6M 0.12% 183
2018
Q2
$58.5M Buy
201,519
+9,866
+5% +$2.86M 0.08% 244
2018
Q1
$52.5M Sell
191,653
-54,177
-22% -$14.8M 0.08% 243
2017
Q4
$78.3M Buy
245,830
+199,140
+427% +$63.4M 0.12% 180
2017
Q3
$14.6M Buy
46,690
+20,400
+78% +$6.39M 0.05% 249
2017
Q2
$7.13M Sell
26,290
-28,054
-52% -$7.61M 0.02% 363
2017
Q1
$14.9M Buy
+54,344
New +$14.9M 0.05% 250
2016
Q4
Sell
-665
Closed -$208K 532
2016
Q3
$208K Sell
665
-434
-39% -$136K ﹤0.01% 535
2016
Q2
$266K Buy
1,099
+219
+25% +$53K ﹤0.01% 548
2016
Q1
$229K Buy
+880
New +$229K ﹤0.01% 539
2015
Q3
Sell
-18,360
Closed -$7.42M 588
2015
Q2
$7.42M Sell
18,360
-112
-0.6% -$45.2K 0.03% 385
2015
Q1
$7.8M Sell
18,472
-121
-0.7% -$51.1K 0.03% 380
2014
Q4
$6.31M Buy
18,593
+17,524
+1,639% +$5.95M 0.02% 416
2014
Q3
$354K Sell
1,069
-163
-13% -$54K ﹤0.01% 600
2014
Q2
$388K Sell
1,232
-19
-2% -$5.98K ﹤0.01% 599
2014
Q1
$383K Sell
1,251
-224
-15% -$68.6K ﹤0.01% 600
2013
Q4
$413K Sell
1,475
-299
-17% -$83.7K ﹤0.01% 582
2013
Q3
$427K Buy
+1,774
New +$427K ﹤0.01% 588